Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow

Mesenchymal stromal cells (MSCs) are promising candidates for novel cell therapeutic applications. For clinical scale manufacturing, human factors from serum or platelets have been suggested as alternatives to fetal bovine serum (FBS). We have previously shown that pooled human serum (HS) and thrombin‐activated platelet releasate in plasma (tPRP) support the expansion of adipose tissue‐derived MSCs. Contradictory results with bone marrow (BM)‐derived MSCs have initiated a comprehensive comparison of HS, tPRP, and pooled human platelet lysate (pHPL) and FBS in terms of their impact on MSC isolation, expansion, differentiation, and immunomodulatory activity. In addition to conventional Ficoll density gradient centrifugation, depletion of lineage marker expressing cells (RosetteSep) and CD271+ sorting were used for BM‐MSC enrichment. Cells were cultured in medium containing either 10% FBS, HS, tPRP, or pHPL. Colony‐forming units and cumulative population doublings were determined, and MSCs were maximally expanded. Although both HS and tPRP comparable to FBS supported isolation and expansion, pHPL significantly accelerated BM‐MSC proliferation to yield clinically relevant numbers within the first two passages. MSC quality and functionality including cell surface marker expression, adipogenic and osteogenic differentiation, and immunosuppressive action were similar in MSCs from all culture conditions. Importantly, spontaneous cell transformation was not observed in any of the culture conditions. Telomerase activity was not detected in any of the cultures at any passage. In contrast to previous data from adipose tissue‐derived MSCs, pHPL was found to be the most suitable FBS substitute in clinical scale BM‐MSC expansion. STEM CELLS 2009;27:2331–2341

[1]  S. Ikehara,et al.  Selective culture of mesodermal progenitor cells. , 2009, Stem cells and development.

[2]  P. Leoni,et al.  Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow. , 2009, Cytotherapy.

[3]  A. Kiani,et al.  Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium , 2009, Bone Marrow Transplantation.

[4]  I. Martin,et al.  Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. , 2009, Tissue engineering. Part A.

[5]  D J Williams,et al.  Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. , 2008, Journal of biotechnology.

[6]  A. Reinisch,et al.  Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. , 2008, Tissue engineering. Part C, Methods.

[7]  J. Blanco,et al.  Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. , 2008, Experimental hematology.

[8]  D. Strunk,et al.  Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells , 2008, Transfusion Medicine and Hemotherapy.

[9]  C. Choong,et al.  PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. , 2008, Blood.

[10]  A. Ho,et al.  Optimizing BM harvesting from normal adult donors , 2008, Bone Marrow Transplantation.

[11]  J. Folkman,et al.  Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.

[12]  O. Myklebost,et al.  High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence , 2007, Journal of cellular and molecular medicine.

[13]  Smadar Cohen,et al.  Signal transducer and activator of transcription 3-A key molecular switch for human mesenchymal stem cell proliferation. , 2008, The international journal of biochemistry & cell biology.

[14]  P. Collas,et al.  Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. , 2008, The International journal of developmental biology.

[15]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[16]  Andrej-Nikolai Spiess,et al.  Accelerated and safe expansion of human mesenchymal stromal cells in animal serum‐free medium for transplantation and regenerative medicine , 2007, Journal of cellular physiology.

[17]  O. Ringdén,et al.  No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients , 2007, Haematologica.

[18]  M. Introna,et al.  Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts , 2007, Bone Marrow Transplantation.

[19]  Dirk Strunk,et al.  Two steps to functional mesenchymal stromal cells for clinical application , 2007, Transfusion.

[20]  Karl Kashofer,et al.  Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells , 2007, Transfusion.

[21]  Andreas Reinisch,et al.  Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. , 2007, Regenerative medicine.

[22]  Zhe Wang,et al.  Cytogenetic analysis of human bone marrow‐derived mesenchymal stem cells passaged in vitro , 2007, Cell biology international.

[23]  H. Klüter,et al.  Human AB Serum and Thrombin‐Activated Platelet‐Rich Plasma Are Suitable Alternatives to Fetal Calf Serum for the Expansion of Mesenchymal Stem Cells from Adipose Tissue , 2007, Stem cells.

[24]  A. Cometa,et al.  Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute , 2007, Journal of cellular physiology.

[25]  J. Laine,et al.  N‐Glycolylneuraminic Acid Xenoantigen Contamination of Human Embryonic and Mesenchymal Stem Cells Is Substantially Reversible , 2007, Stem cells.

[26]  A. Hardikar,et al.  Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells , 2006, In Vitro Cellular & Developmental Biology - Animal.

[27]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[28]  D. G. Halme,et al.  FDA regulation of stem-cell-based therapies. , 2006, The New England journal of medicine.

[29]  Jeffrey L. Spees,et al.  Enhanced Engraftment of Mesenchymal Stem Cells in a Cutaneous Wound Model by Culture in Allogenic Species‐Specific Serum and Administration in Fibrin Constructs , 2006, Stem cells.

[30]  Hermann Eichler,et al.  Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue , 2006, Stem cells.

[31]  R. Handgretinger,et al.  Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. , 2006, Cytotherapy.

[32]  S. Chiou,et al.  Using human plasma supplemented medium to cultivate human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. , 2005, Transplantation proceedings.

[33]  X. Holy,et al.  Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications , 2005, Journal of cellular physiology.

[34]  Katrine Frønsdal,et al.  In Vitro Expansion of Human Mesenchymal Stem Cells: Choice of Serum Is a Determinant of Cell Proliferation, Differentiation, Gene Expression, and Transcriptome Stability , 2005, Stem cells.

[35]  H. Higuchi,et al.  Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum. , 2005, The Journal of bone and joint surgery. British volume.

[36]  J. Cazenave,et al.  Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set , 2005, Transfusion.

[37]  J. Cigudosa,et al.  Spontaneous human adult stem cell transformation. , 2005, Cancer research.

[38]  A. Zander,et al.  Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. , 2004, Experimental hematology.

[39]  H. Klüter,et al.  Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood , 2004, Stem cells.

[40]  H. Klüter,et al.  Fully automated processing of buffy‐coat–derived pooled platelet concentrates , 2004, Transfusion.

[41]  G. Cagney,et al.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. , 2004, Blood.

[42]  H. Eichler,et al.  Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. , 2003, Journal of immunological methods.

[43]  M. Yamaguchi,et al.  Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion , 2002, Transfusion.

[44]  D. Soligo,et al.  Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. , 2002, Experimental hematology.

[45]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Gronthos,et al.  Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. , 2001, Bone.

[47]  P. Robey,et al.  EFFECT OF SERUM ON HUMAN BONE MARROW STROMAL CELLS: EX VIVO EXPANSION AND IN VIVO BONE FORMATION , 2000, Transplantation.

[48]  R. Oreffo,et al.  Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. , 1997, European journal of cell biology.

[49]  Peter Harrison,et al.  Platelet a-granules , 1993 .

[50]  Paul J. Harrison,et al.  Platelet alpha-granules. , 1993, Blood reviews.

[51]  W. Chavin,et al.  Fetal Bovine Serum: A Multivariate Standard 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.